Woodline Partners’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Hold |
652,865
| – | – | 0.01% | 755 |
|
|
2025
Q1 | $4.35M | Buy |
652,865
+444
| +0.1% | +$2.96K | 0.03% | 539 |
|
|
2024
Q4 | $8.2M | Buy |
652,421
+51,358
| +9% | +$646K | 0.06% | 389 |
|
|
2024
Q3 | $11.1M | Buy |
601,063
+39,097
| +7% | +$722K | 0.09% | 276 |
|
|
2024
Q2 | $12.1M | Buy |
+561,966
| New | +$12.1M | 0.12% | 226 |
|
|
2023
Q2 | – | Sell |
-326,605
| Closed | -$5.59M | – | 727 |
|
|
2023
Q1 | $5.59M | Buy |
326,605
+106,352
| +48% | +$1.82M | 0.08% | 275 |
|
|
2022
Q4 | $4.31M | Buy |
+220,253
| New | +$4.31M | 0.06% | 340 |
|
|
2022
Q2 | – | Sell |
-142,011
| Closed | -$2.25M | – | 870 |
|
|
2022
Q1 | $2.25M | Buy |
+142,011
| New | +$2.25M | 0.04% | 365 |
|